La maladie de Parkinson en France (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Oxidopamine (pharmacology) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Oxidopamine (metabolism) < Oxidopamine (pharmacology) < Oxidopamine (toxicity)  Facettes :

List of bibliographic references indexed by Oxidopamine (pharmacology)

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000236 (2016) Carine Chassain [France] ; Christophe Melon [France] ; Pascal Salin [France] ; Flora Vitale [France] ; Sébastien Couraud [France] ; Franck Durif [France] ; Lydia Kerkerian-Le Goff [France] ; Paolo Gubellini [France]Metabolic, synaptic and behavioral impact of 5-week chronic deep brain stimulation in hemiparkinsonian rats.
000500 (2015) Carole Carcenac [France] ; Mathieu Favier [France] ; Yvan Vachez [France] ; Emilie Lacombe [France] ; Sébastien Carnicella [France] ; Marc Savasta [France] ; Sabrina Boulet [France]Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats.
001143 (2012) C. Delaville [France] ; S. Navailles ; A. BenazzouzEffects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
001A40 (2010) Christelle Baunez [France] ; Paolo GubelliniEffects of GPi and STN inactivation on physiological, motor, cognitive and motivational processes in animal models of Parkinson's disease.
002927 (2006) Emilie Giaime [France] ; Claire Sunyach ; Magali Herrant ; Sébastien Grosso ; Patrick Auberger ; Pamela J. Mclean ; Frédéric Checler ; Cristine Alves Da CostaCaspase-3-derived C-terminal product of synphilin-1 displays antiapoptotic function via modulation of the p53-dependent cell death pathway.
002936 (2006) Cristine Alves Da Costa [France] ; Julie Dunys ; Frédéric Brau ; Sherwin Wilk ; Roberto Cappai ; Frédéric Checler6-Hydroxydopamine but not 1-methyl-4-phenylpyridinium abolishes alpha-synuclein anti-apoptotic phenotype by inhibiting its proteasomal degradation and by promoting its aggregation.
002E35 (2004) Jean-Christophe Corvol [France] ; Marie-Paule Muriel ; Emmanuel Valjent ; Jean Féger ; Naïma Hanoun ; Jean-Antoine Girault ; Etienne C. Hirsch ; Denis HervéPersistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.
003009 (2004) Jean-Jacques Bacci [France] ; Philippe Kachidian [France] ; Lydia Kerkerian-Le Goff [France] ; Pascal Salin [France]Intralaminar thalamic nuclei lesions: Widespread impact on dopamine denervation-mediated cellular defects in the rat basal ganglia
003086 (2003) Cristine Alves Da Costa [France] ; Eliezer Masliah ; Frédéric CheclerBeta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.
003137 (2003) Yassine Darbaky [France] ; Claude Forni [France] ; Marianne Amalric [France] ; Christelle Baunez [France]High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task
003320 (2002) Pascal Salin [France] ; Christine Manrique ; Claude Forni ; Lydia Kerkerian-Le GoffHigh-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the basal ganglia in the rat.
003330 (2002) Cristine Alves Da Costa [France] ; Erwan Paitel ; Bruno Vincent ; Frédéric CheclerAlpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson's disease.
004834 (1995) M. Amalric [France] ; H. Moukhles [France] ; A. Nieoullon [France] ; A. Daszuta [France]Complex Deficits on Reaction Time Performance following Bilateral Intrastriatal 6‐OHDA Infusion in the Rat
004A86 (1994) P. Horellou [France] ; E. Vigne [France] ; M.-N. Castel [France] ; P. Barneoud [France] ; P. Colin [France] ; M. Perricaudet [France] ; P. Delaere [France] ; J. Mallet [France]Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Oxidopamine (pharmacology)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Oxidopamine (pharmacology)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Oxidopamine (pharmacology)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024